A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Clinical trial NCT00532155 · COMPLETED

Trial details

NCT number: NCT00532155
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma Non Small Cell Lung

Start date: 2007-09-01
Primary completion: 2011-01-01
Enrollment: 913

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.